NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in t...
Q1 2026
May 15, 2026
FY 2025
Mar 23, 2026
Q4 2025
Q3 2025
Nov 14, 2025
Q2 2025
Aug 18, 2025
